Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update.
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease and represents the main cause of sudden death in young patients. Cardiac magnetic resonance (CMR) and cardiac computed tomography (CCT) are noninvasive imaging methods with high sensitivity and specificity, useful for the establishment of diagnosis and prognosis of HCM, and for the screening of patients with subclinical phenotypes. The improvement of image analysis by CMR and CCT offers the potential to promote interventions aiming at stopping the natural course of the disease. This study aims to describe the role of RCM and CCT in the diagnosis and prognosis of HCM, and how these methods can be used in the management of these patients.
Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil.
Diogo Costa Leandro de
DC
Oliveira
Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil.
Fernanda Boldrini
FB
Assunção
Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil.
Alair Agusto Sarmet Moreira Damas Dos
AA
Santos
Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil.
Marcelo Souto
MS
Nacif
D002312:Cardiomyopathy, Hypertrophic / Q000000981:diagnostic imaging*; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D008279:Magnetic Resonance Imaging / Q000379:methods*; D019028:Magnetic Resonance Imaging, Cine / Q000379:methods; D011379:Prognosis; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed / Q000379:methods*